000 | 01089 a2200265 4500 | ||
---|---|---|---|
005 | 20250513031914.0 | ||
264 | 0 | _c19951012 | |
008 | 199510s 0 0 eng d | ||
022 | _a0091-7370 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLazarchick, J | |
245 | 0 | 0 |
_aThe effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. _h[electronic resource] |
260 |
_bAnnals of clinical and laboratory science _c |
||
300 |
_a306-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aBlood Coagulation Disorders _xchemically induced |
650 | 0 | 4 |
_aDeamino Arginine Vasopressin _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxyethyl Starch Derivatives _xadministration & dosage |
650 | 0 | 4 | _aIntraoperative Period |
650 | 0 | 4 |
_avon Willebrand Diseases _xchemically induced |
650 | 0 | 4 |
_avon Willebrand Factor _xmetabolism |
700 | 1 | _aConroy, J M | |
773 | 0 |
_tAnnals of clinical and laboratory science _gvol. 25 _gno. 4 _gp. 306-9 |
|
999 |
_c7544844 _d7544844 |